Introduction
Hepatocyte Growth Factor/Scatter Factor was ®rstly characterized as a mitogen for primary hepatocytes and subsequently as a mitosis and motility factor for a number of epithelial and endothelial cells (Michalopoulos and DeFrances, 1997; Bussolino et al., 1992; Weidner et al., 1993) . HGF/SF signals through its receptor encoded by the product of the c-met oncogene endowed with intrinsic tyrosine kinase activity (Naldini et al., 1991a,b; Bottaro et al., 1991) . The HGF/SF receptor possesses a multifunctional docking site located at the C-terminus and extended within the Y* 1349 -VHVNAT-Y* 1356 -VNV motif (Ponzetto et al., 1994) , also conserved in the MET-related receptors Sea and Ron (Maestrini et al., 1996) . It mediates high anity interactions with Src homology 2 (SH2)-containing transducers including phosphoinositide 3-kinase (PI 3-K), phospholipase C-gamma (PLC-g), pp60
src and Grb-2-Sos (Bardelli et al., 1992) . PI 3-K, the small GTPbinding protein Ras and functional intracellular Ras, were shown to mediate primarily the cell dissociation and motility signal of HGF/SF (Royal and Park, 1995; Ridley et al., 1995; Hartmann et al., 1994) .
The HGF/SF receptor motility signal may be integrated via interactions with the cortical cytoskeleton, and more speci®cally, with actin-binding partners (Dowrick et al., 1991; Bray et al., 1986) . Such interactions include changes in the assembly, the length and the polymerization of actin ®laments occurring via tyrosine phosphorylation of actin-bound partners potentially mediated by the Src kinases (Parsons and Weber, 1989; Sabe et al., 1997; Hamaguchi et al., 1988) .
An important actin-binding partner is cortactin which appears in two forms (p80/p85) and possesses a sevenfold repeat motif responsible for in vitro binding to F-actin, a Src-homology 3 (SH3) domain and a proline-rich region (Wu and Parsons, 1993; Wu et al., 1991) . It is primarily localized within peripheral cell structures such as lamelipodia, pseudopodia and membrane rues and has been suggested to operate as a potential linker between membrane-located receptors and the cytoskeleton, primarily aecting cell motility and invasion (Van Damme et al., 1997; Patel et al., 1998) . It is phosphorylated on serine and threonine and also on tyrosine upon cell stimulation with growth factors (FGF) or transformation by activated Src (Vuori and Ruoslahti, 1995; Zhan et al., 1993 Zhan et al., , 1994 . Growth factor-activated Rac1 was shown to direct redistribution of cortactin from the cytoplasm into membrane rues (Weed et al., 1998) .
Cortactin also forms complexes with the SH2 domain of non-receptor tyrosine kinases including Src and FER and with receptor tyrosine kinase-activated transducers, as reported for Epidermal Growth Factor protein Substrate-8 (Eps8) (Huang et al., 1997; Kim and Wong, 1998; Provenzano et al., 1998) . Tyrosines located between the proline-rich sequence and the SH3 domain of cortactin (Tyr 421, 466, 482 ) were targeted by Src kinase and mutation of these sites abrogated migration of endothelial cells (Huang et al., 1998) .
In this study we investigated potential interactions of the HGF/SF receptor beta-subunit with the cytoskeleton and the F-actin binding partners. We report that HGF/SF induces tyrosine phosphorylation of p80/85 cortactin which was independent of endogenous Src kinase activity. Cortactin associated with the betasubunit of the HGF/SF receptor and Grb2 was also found in the cortactin-p145 bMET immunoprecipitate. A431 cells transfected with Grb2 dominant-negative expression constructs lacking either the C-SH3-Grb2 domain or both the C,N-SH3-Grb2 domains, failed to phosphorylate cortactin in response to HGF/SF. We propose that cortactin may operate as a docking site for the MET signal to the cytoskeleton.
Results
HGF/SF induces tyrosine phosphorylation of cortactin which associates in vivo with HGF/SF receptor beta-subunit A431 human epidermal carcinoma cells are known to respond to HGF/SF mainly by scattering and bear high anity HGF receptor sites (Tajima et al., 1992) . Cortactin (p80/85) was found to be expressed in high abundance in A431 cells and we tested whether HGF/ SF could stimulate phosphorylation of p80/85 in serum-starved cells ( Figure 1A ). Cell lysates immunoprecipitated with anti-cortactin monoclonal antibody (4F11) were resolved by SDS ± PAGE and immunoblotted with anti-phosphotyrosine (PY99) antibody. The 4F11 antibody immunoprecipitated tyrosine-phosphorylated species migrating at 80/85 Kda. Under these conditions, phosphorylation of p80/85 increased with time, reaching a maximum at 30 min post-stimulation with HGF/SF and returned to control levels within 3 ± 6 h.
4F11 immunoprecipitates contained similar amounts of cortactin ( Figure 1B ) and scanning densitometry of the peak areas has revealed that cortactin phosphorylation was increased approximately 3.5-fold, compared to the control (0 min), by 30 min after addition of HGF/SF ( Figure 1C ).
Another major phosphorylated band was detected in cortactin immunoprecipitates, migrating at approximately 150 Kda. After stripping and re-probing the blots with anti-MET it was revealed that the phosphorylated protein corresponded to the betasubunit of the HGF/SF receptor (p145 bMET ) ( Figure  1A ,D). Phosphorylation of p145
bMET followed the same time pattern as that of cortactin, reaching maximum phosphorylation 30 min after stimulation with HGF/ SF. Maximal association of the MET beta-subunit with cortactin was also observed between 10 ± 30 min poststimulation. A further experiment was carried out to con®rm cortactin phosphorylation, by immunoblotting HGF/SF-treated or untreated PY99 immunoprecipitates, with 4F11 ( Figure 1E ).
Increasing concentrations of HGF/SF induced a proportional increase in cortactin phosphorylation detected in 4F11 immunoprecipitates, which were shown to contain equal amounts of cortactin ( Figure  1F ,G).
The next issue was to examine whether the increased tyrosine phosphorylation of cortactin was due to its increased synthesis induced by HGF/SF. Lysates from serum-starved A431 cells were immunoblotted and probed with 4F11 ( Figure 1H ). Addition of HGF/SF did not seem to alter the steady-state levels of cortactin throughout all time points.
Cortactin associates with the beta-subunit of the HGF/SF receptor To further con®rm co-immunoprecipitation with the beta-subunit of the HGF/SF receptor, MET immunoprecipitates were immunoblotted with PY99 and 4F11 antibodies (Figure 2A,B) . Indeed, cortactin was detected in MET immunoprecipitates containing equal amounts of p145
bMET and the levels of associated cortactin were increased approximately threefold compared to the unstimulated immunoprecipitates ( Figure 2A) .
The capacity of GST-cortactin fusion proteins to associate in vitro with MET species was then investigated ( Figure 2C,D) . The total amount of MET species was ®rstly evaluated by immunoprecipitating MET species, then immunoblotted with anti-MET (Figure 2Da ). This panel shows total cellular MET, 0 min ± 3 h following addition of HGF/SF (Figure 2Da ,1 ± 5).
Lysates from A431 cells stimulated with HGF/SF for various times, were incubated with GST, GSTcortactin (full length), and . Full length GST-cortactin and N-terminal cortactin associated with MET betasubunit, although C-cortactin was unable to bind MET (Figure 2Db ± d ).
Cortactin associates with Grb2 in HGF/SF-dependent manner Grb2, a small adapter protein, links tyrosine kinase receptors with Ras signalling by forming a complex with the Ras guanyl-nucleotide exchanger Sos and/or Shc. Grb2-SoS binds Y 1356 within the YVNV motif of the C-terminal MET docking site (Ponzetto et al., 1996) . Grb2, possesses a central SH2 domain recruited and tyrosine phosphorylated by p145 bMET . Grb2 is required to transduce the proliferating, scattering and invasive signal to downstream eectors and via its N and/or C-SH3 domains may function as a bridge between the beta-subunit of MET and cortactin (Ponzetto et al., 1994 (Ponzetto et al., , 1996 . To explore this possibility, cortactin immunoprecipitates ( Figure 1A ) were probed with anti-Grb2. Grb2 was detected in 4F11 (cortactin) immunoprecipitates and the levels of associated Grb2 were increased proportionally with time after HGF/SF stimulation ( Figure 3A ). On the other hand, the p85 subunit of phosphoinositide 3-Kinase, also phosphorylated by the MET beta-subunit, was not associated with cortactin although MET immunoprecipitates contained PI 3-kinase activity (not shown). We have carried out a number of binding assays using the three GST cortactin proteins reacted with total cell lysates which were then immunoblotted with anti-Grb2. We have been unable to detect association of Grb2 with GST 294 ± 526 cortactin (which includes the proline-rich region) although both full-length and GST 55 ± 292 cortactins were associated with Grb2 (not shown).
To evaluate the percentage of Grb2 associated with cortactin and MET, cellular Grb2 from HGF/SF- Figure 1 Tyrosine phosphorylation of cortactin in response to HGF/SF and its association in vivo with the beta-subunit of the HGF/SF receptor. Cell lysates from serum-starved or HGF/SF-treated (50 ng/ml) A431 cells, were immunoprecipitated with the 4F11 (anti-cortactin) antibody, and immunoprecipitates were resolved by SDS ± PAGE and immunoblotted with antiphosphotyrosine (PY99) antibody (A) resolved immunoprecipitates. The blot was stripped and re-probed with 4F11 (B) for equal loading control. The autoradiogram shown in (A) was scanned with an LKB Ultrascan XL densitometer to quantify p80/85 reactive area (C). Bars represent fold increase in cortactin phosphorylation compared to unstimulated controls (A : 1). The blot shown in (A) was further probed with anti-MET antibody (D). To visualize cortactin in the HGF/SF-treated lysates, immunoprecipitation of HGF/SF-treated and untreated lysates was carried out with PY99 followed by immunoblotting with 4F11 (E). Lysates from A431 cells stimulated with increasing concentrations of HGF/SF were immunoprecipitated with 4F11 and immunoblotted either with PY99 (F) or 4F11 (G). Potential variation in the expression of cortactin in A431 following stimulation with HGF/SF is illustrated in blot (H) which shows total cell lysate protein (150 mg) from A431 cells treated with HGF/SF for the indicated times, immunoblotted with 4F11. The results shown here are representative of an average of 2 ± 3 identical experiments Oncogene Phosphorylation of cortactin in response to HGF/SF L Crostella et al treated lysates was immunoprecipitated and immunoblotted with anti-Grb2 ( Figure 3B ). Stimulation with HGF/SF did not alter total cellular Grb2. HGF/SFtreated lysates immunoprecipitated with anti-MET and immunoblotted with anti-Grb2 have shown that a signi®cant amount of Grb2 is bound to the betasubunit ( Figure 3C ). Quantitation of Grb2 bound to the beta-subunit by scanning densitometry revealed that approximately 60% of total Grb2 is bound to MET, whereas only 18% of Grb2 binds MET in unstimulated lysates ( Figure 3D ).
Intact cytoskeleton is required for cortactin phosphorylation in response to HGF/SF A431 cells were treated with cytochalasin D at concentrations known to disrupt actin organization (Van Itallie et al., 1995) and with HGF/SF, to stimulate phosphorylation of cortactin ( Figure 4A ). 4F11 immunoprecipitates from A431 cells treated with or without cytochalasin D, were immunoblotted with PY99 and 4F11. Cytochalasin D used at both concentrations abrogated cortactin phosphorylation in response to HGF/SF, although it did not seem to inhibit the beta-subunit autophosphorylating capacity ( Figure 4C ).
Epidermal Growth Factor Receptor Protein Substrate-8 (Eps8), possessing an SH3 domain, is a tyrosine kinase substrate (EGF-R) shown to be colocalized with cortactin and F-actin (Provenzano et al., 1998 ). Eps8 appears as a 97 and 68-Kda forms and the antibody we have used had shown speci®city to recognize both forms of Eps8. Crk possesses two SH3 domains and contains three PXXP motifs, potentially selected by a number of eectors, including cortactin (Sparks et al., 1996) . It was tested whether Eps8 and Crk could associate with cortactin. We were able to visualize co-immunoprecipitation of both Eps8 and Crk with cortactin by immunoblotting Eps8 and Crk immunoprecipitates with 4F11 ( Figure Phosphorylation of cortactin in response to HGF/SF L Crostella et al whereas Eps8 and cortactin were enriched in membrane rues and lamellipodia of serum-stimulated cells (Provenzano et al., 1998) . Stimulation with HGF/SF did not seem to aect the association of cortactin with either Eps8 or Crk, this implying that these transducers may not be involved in the`presentation' of cortactin to the MET kinase.
The HGF/SF receptor beta-subunit associated with detergent-insoluble cell fraction
To investigate further the association of cortactin with the beta-subunit of the HGF/SF receptor, detergent-soluble and insoluble (cytoskeletal) cell fractions from HGF/SF-stimulated A431 cells were prepared ( Figure 5 ). p145 bMET was found in both fractions from A431 cells treated with or without HGF/SF. For the ®rst time the HGF/SF receptor beta-subunit is enriched in the detergent-insoluble fraction, independently of the presence of HGF/SF. It should be noted that addition of HGF/SF induced a slight increase in MET levels in the detergentinsoluble fraction ( Figure 5A ).
The detergent-insoluble MET beta-subunit possessed signi®cant tyrosine kinase activity, revealed by in vitro kinase assays using Myelin Basic Protein (MBP) as substrate (not shown). MET localization was also monitored using varying concentrations of Triton X-100. At 0.1% Triton X-100 the amount of MET present in detergent-soluble or insoluble fraction did not vary compared to 1% (not shown).
We next examined the localization of cortactin by probing detergent-soluble and insoluble fractions, with 4F11 ( Figure 5A,B) . Cortactin mostly associated with the detergent-insoluble fraction although it became detectable in the soluble fraction, 60 min after HGF/ SF stimulation ( Figure 5B ). We have followed cortactin's localization for up to 72 h using the immunoblotting approach of detergent-soluble and insoluble fractions. Cortactin's distribution is stable beyond 5 h post-HGF at approximately 70% insoluble : 30% soluble. This observation is in agreement with other reported studies and cortactin in both fractions is able to interact with the MET beta-subunit.
The previous results showing co-association of cortactin with MET and Grb2 prompted us to explore the localization of Grb2. Indeed, a signi®cant percen- Figure 3 Grb2 associates with cortactin in a HGF/SF-dependent manner. To identify association of Grb2 with cortactin, the blot shown in Figure 1A was stripped and re-probed with anti-Grb2 (Transduction Laboratories) (A). Lanes 1 ± 6 represent 4F11 immunoprecipitates of lysates treated with HGF/SF for 0, 2, 10, 30, 60 and 180 min, respectively (A). Total cellular Grb2 is visualized in immunoprecipitates (1.5 mg lysate protein) immunoblotted with anti-Grb2 (B). To identify the amount of Grb2 bound to the beta-subunit of the HGF/SF receptor, A431 lysates treated with HGF/SF for 0 ± 180 min, were immunoprecipitated with anti-MET and immunoblotted with anti-Grb2 (C). Peak areas in autoradiograms (B) and (C) were scanned and per cent of Figure  5A ). Other investigators have reported incorporation of Grb2 into the cytoskeleton in an aggregationdependent fashion (Miyakawa et al., 1997) .
Scanning densitometry of the detergent-insoluble associated MET, cortactin and Grb2 species has revealed that the greater percentage of MET and cortactin was associated with this fraction. In average 60% of Grb2 associated with the detergent-insoluble fraction ( Figure 5C ).
Involvement of endogenous c-Src kinase in cortactin phosphorylation in response to HGF/SF It was then investigated whether the increase in cortactin tyrosine phosphorylation could also be mediated by Src kinases(s). c-Src becomes phosphorylated on tyrosine and is recruited to the MET docking site upon HGF/SF stimulation (Ponzetto et al., 1994) . Therefore, the increase in cortactin phosphorylation could be due, at least in part, to activated Src kinases(s) mediating the MET eect. To elucidate this, A431 cells were stimulated with HGF/SF in the presence or not of PP-2, a potent inhibitor of the Src kinase family (Hanke et al., 1996) (Figure 6A ). Cortactin immunoprecipitates were immunoblotted with PY99. PP-2, at concentrations known to inhibit Src kinase activity (1 ± 10 mM) (Rodriguez-Fernandez and Rozengurt, 1998), did not aect tyrosine phosphorylation of cortactin. Ten mM PP-2 also did not aect cortactin phosphorylation, in response to HGF/ SF ( Figure 6A, upper panel) .
Immune-complex kinase assays were carried out to further ascertain that PP-2 was indeed inhibiting Src kinase activity using enolase, a known substrate for Src kinase family members (Rahimi et al., 1998) . Endogenous c-Src was immunoprecipitated and its kinase activity was measured by the capacity of immunoprecipitated c-Src to phosphorylate enolase on tyrosine, in the presence or absence of PP-2 ( Figure 6B ). PP-2 produced signi®cant inhibition of endogenous c-Src kinase activity added either in the reaction at 1 or 10 mM, or present in culture for the indicated times. Figure 6 Involvement of c-Src kinase in cortactin phosphorylation in response to HGF/SF. A431 lysates from cells treated with or without HGF/SF (50 ng/ml) and/or PP2 (1 or 10 mM) for the indicated times, were immunoprecipitated with 4F11 and immunoblotted with either PY99 or 4F11 antibodies (A). Lysates from serum-starved or HGF/SF-treated A431 cells were immunoprecipitated with anti-c-Src-2 antibody and reactive species were collected in Protein-A agarose beads. Immune-complex kinase assays were carried out in the presence of 10 mCi [g-32 P]ATP and where indicated of PP2 (1 or 10 mM), preincubated for 15 min before addition of the label. Enolase was present in each reaction (4 mg). Some reactions were carried out with immune-complexes originating from A431 cells treated with HGF/SF and PP2 at 1 or 10 mM in culture, also in the presence of enolase (B). Reactions were stopped by adding hot 46Laemmli sample buer, heated for 4 min and resolved by SDS ± PAGE. One half of the immune-complex assays was separated by 10% SDS ± PAGE and immunoblotted with anti-c-Src-2 antibody to determine equal content of the immunoprecipitates (C). Autoradiograms (from B) were scanned and per cent inhibition of Src kinase activity compared to the positive control (B, lane 2) was quanti®ed by densitometry (D). Bars represent values from at least three identical and independent experiments Phosphorylation of cortactin in response to HGF/SF L Crostella et al Addition of PP-2 in the kinase assay at 1 mM, left some residual Src kinase activity. One-half of the kinase reaction was separated by SDS ± PAGE and immunoblotted with anti-Src-2 antibody (Santa Cruz) and equal amounts of c-Src were visualized ( Figure 6C ). MET tyrosine kinase activity was not aected by the presence of PP-2 (1 mM) as further evaluated by immune-complex kinase assays in the presence of [g-32 PATP] (not shown). The ability of MET and Src to co-immunoprecipitate, in either MET or Src immunoprecipitates, immunoblotted with the respective antibodies, was also tested. In both cases, similar trace amounts of Src and MET were detectable in MET and Src immunoprecipitates, respectively (not shown).
Grb2 domains involved in the association with cortactin and their role in HGF/SF-induced cortactin phosphorylation
In order to verify which domains of Grb2 mediate the association with cortactin, GST-Grb2 fusion proteins ( Figure 7A , upper panel) immobilized on GSTSepharose beads were incubated with A431 cell lysates originating from HGF/SF-treated or untreated cells. Bound species were eluted from the beads, separated by SDS ± PAGE and immunoblotted with anti-MET and 4F11. GST-Grb2 proteins bound MET species from HGF/SF-treated lysates whereas GST-Grb2 lacking the SH2 domain ( Figure 7A , lower panel 5) failed to bind MET. This con®rmed that the SH2 domain mediates the association of Grb2 with the MET docking site.
Probing the blot with 4F11 revealed that full length, GST-N-SH3 Grb2 and GST-Grb2 lacking the SH2 domain were able to bind cortactin in HGF/SF-treated lysates ( Figure 7A, lower panel: 1,2,5 ). This set of results suggests that the Grb2-SH2 domain is not likely to be involved in Grb2-cortactin interactions (association) ( Figure 7A, lower panel) .
In contrast GST-Grb2 lacking either the C-SH3 or both the N and C-SH3 domains, failed to associate with cortactin. These results indicated that the C-SH3 domain might play a central role in the association of cortactin-Grb2.
To elucidate further the role of Grb2 domains in cortactin phosphorylation and association, A431 cells were transiently transfected with wild-type and dominant-negative Grb2 expression constructs ( Figure 7B and left panel). After transfection, starvation and stimulation with HGF/SF, 4F11 immunoprecipitates were immunoblotted with PY99 and then with 4F11. Cells transfected with dominant-negative Grb2 constructs lacking the C-SH3 domain (W193K) as well as the W36,193K (lacking both C,N-SH3 domains) failed to phosphorylate cortactin in response to HGF/SF. Transfection with wild-type Grb2 did not aect the levels of cortactin phosphorylation. These data support a major role of the Grb2 C-SH3 domain in mediating cortactin phosphorylation. In contrast, the R86K (lacking the SH2 domain) construct did not abrogate cortactin phosphorylation suggesting that the SH2 domain may not be required in MET-cortactin/Grb2 interactions. This is further supported by the ®nding that the dominant-negative expression construct lacking the SH2 domain (R86K) was active in terms of blocking the association of MET with endogenous Grb2 (not shown).
Phosphorylation of cortactin in vitro by the Src kinase occurs between the proline-rich sequence and the Src homology 3 domain. It has been shown that mutations at tyrosines within that region (Tyr ) signi®cantly reduced Src-mediated tyrosine phosphorylation in ECV304 cells (Huang et al., 1998) . We have generated stable A431 clones expressing a Myc-tagged cortactin mutant (MycCort F421F466F482 ) and studied its potential to alter cell migration in response to HGF/SF (Figure 8 ). Cell lysates from transfected cells were immunoblotted with 9E10 antibody and were found to express the Myc tag (Figure 8 ). Cell migration was measured at dierent time points after stimulation with HGF/SF and was found to be signi®cantly impaired (Figure 8 ). On the other hand over-expression of wild-type Myc-Cortactin Figure 7 Binding of GST-Grb2 fusion proteins to MET and cortactin and eects of dominant-negative Grb2 expression on HGF/SF-induced cortactin phosphorylation. GST-Grb2 fusion proteins (upper panel A) and wild-type Grb2 and dominantnegative constructs (upper panel B) were prepared as detailed in Materials and methods. Boxes represent the Grb2 domains with stripes the N-SH3, the shaded the SH2 and white the C-SH3. GST-Grb2 fusion proteins (1 ± 5) were incubated with A431 lysates from cells treated with or without HGF/SF (50 ng/ml) for 15 min. Sepharose-bound proteins were resolved by SDS ± PAGE and immunoblotted with anti-MET and after stripping with 4F11 (lower panel A). Wild type or dominant-negative Grb2 constructs (upper panel B) were transiently imported into A431 cells which were subsequently stimulated with HGF/SF (50 ng/ml) for 15 min. Lysates were immunoprecipitated with 4F11, resolved by 10% SDS ± PAGE and immunoblotted with either PY99 (left) or 4F11 (B). Blots shown here are representative of at least two independent experiments Oncogene Phosphorylation of cortactin in response to HGF/SF L Crostella et al in A431 cells did not alter signi®cantly cell migration in response to HGF/SF. These data support the hypothesis that these tyrosine residues are common targets for MET and Src kinases.
Over-expression of cortactin or increased tyrosine phosphorylation has been related to its translocation to the cell-matrix contact sites and with distortion of actin micro®laments. Migration of tyrosine phosphorylated cortactin to the cell-matrix contact sites coincides with the appearance of structures with decreased adhesive capacity (podosomes) (Van Damme et al., 1997) .
Cortactin is phosphorylated on tyrosine in response to various growth factors (Yamanashi et al., 1997; Zhan et al., 1993) however to our knowledge, in vivo association with receptor tyrosine kinases has not been reported. This clearly postulates a role for cortactin as a key transducer mediating MET signals, as this molecule in phosphorylated form confers a motility advantage to epithelial cells (Huang et al., 1998) . The Grb2 adapter was found to localize in both the detergent-soluble and insoluble fraction, thus supporting the evidence for its association with p80/85 cortactin. Grb2 antibodies were reported to inhibit both cell proliferation and growth factor-induced membrane ruing as a GST-Grb2 protein injected into cells co-localized into membrane rues (Bar-Sagi et al., 1993) . In addition Gab1, a Grb2-binding protein sharing similarity with the insulin-receptor substrates (IRS), also associates with the MET receptor and preferentially localizes at cell-to-cell contact sites (Weidner et al., 1996) .
We speculate that Grb2 and cortactin may be in loose contact within the cell cortex with their association becoming tighter upon cell stimulation with HGF/SF, which leads to extension of lamellae and formation of circular rues, both characteristics of increased cell spreading (Dugina et al., 1995) . Association of Grb2 with Trp-Met, an oncogenic version of cmet, is essential for transformation of ®broblasts . Downstream targets of Grb2 potentially involved in Tpr-Met transformation, include Gab1 and Cbl . On the other hand, loss of the link between Grb2 and HGF/SF receptor (by mutating Y 1356 within the YVNV motif) is permissive for cell motility, suggesting that the scattering response may be reached by using alternative routes such as through direct recruitment of Shc by the MET receptor (Ponzetto et al., 1996; Fournier et al., 1996) . Rac1 drives another mechanism, which was also shown to operate in HGF/SF-induced scattering. Microinjection of a dominant-negative Rac1 into MDCK cells prevented actin reorganization and HGF/SF-induced scattering (Ridley et al., 1995) . Therefore, Rac1 may be an important mediator of motility signals through re-localization of cortactin to the cell cortex. In accordance to this, a dominantnegative Rac1 blocked translocation of cortactin to the membrane rues (Weed et al., 1998) .
Our data suggest two alternative models of interaction between the Met kinase and cortactin, either via direct recruitment of cortactin by the cytoskeletonembedded Met and/or indirectly, with the MET kinase ®rst engaging Grb2 (via its SH2 domain) which subsequently recruits cortactin to a ternary complex. Both mechanisms (direct/indirect) could operate, this leading to the ampli®cation of the initiatory signal. The majority of cortactin seems to be recruited directly to the beta-subunit as well as Grb2 via its SH2 domain (both events occur very shortly upon HGF addition). At a later stage, it is possible that a small percentage of cortactin is additionally recruited to the MET betasubunit through association with Grb2. This event also coincides with the appearance of cortactin in the detergent-soluble fraction (1 h) which could indeed favour Grb2/Cortactin interactions. We may speculate that Grb2 might be responsible for recruiting cortactin preferably to the soluble percentage of MET.
The role of the family of v-Src kinases in actin ®lament-disorganization and in decreasing cell adherence to the ExtraCellular Matrix, is well documented (Parsons and Weber, 1989; Sabe et al., 1997) . Cortactin becomes phosphorylated on tyrosine by cells transformed by activated v-Src (Zhan et al., 1993) . c-Src was found to associate transiently with cortactin in response to FGF-1 and to thrombin (Zhan et al., 1993; Weidner et al., 1993) and also to phosphorylate cortactin in vitro (Huang et al., 1997; 1998) . It is not yet known whether the Src kinase-targeted tyrosine sites in cortactin and its HS1 counterpart, are also targeted by the Met kinase (Huang et al., 1998; Yamanashi et al., 1997; Brunati et al., 1995) . Src kinases are actively involved in mediating the HGF/SF motility signal and a double mutant of c-Src signi®cantly aected the HGF/SF-induced motility of SP1 intraductal cells over-expressing HGF/SF and MET (Rahimi et al., 1998) . Moreover, the Met receptor is reported to phosphorylate downstream targets not possessing SH2 domains and without the mediation of Src or other intracellular kinases (Cbl, lipocortin) Skouteris and SchroÈ der, 1996) . In addition to that, Gab1 binds the bidentate docking site of MET via its proline-rich domain (Met-binding domain, MBD) located within amino acid residues 450 ± 532 (Weidner et al., 1996) . This further supports the idea that alternative modes of interaction may operate, not involving SH2-phosphotyrosine binding.
Materials and methods

Cells and materials
A431 human epidermoid carcinoma cells were obtained from Imperial Cancer Research Fund cell bank (London, UK) and grown in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% foetal bovine serum (FBS, Helena Laboratories, Inc) in a 5% CO 2 -humidi®ed atmosphere. Cells were serum-starved for 2 days and stimulated, where appropriate, with 50 ng/ml of HGF/SF for various times. HGF/SF was a kind gift from Genentech, Inc. (USA). Chemicals were purchased from Sigma Chemical Co. and anti-MET, anti-c-Src-2 and PTyr (PY99) antibodies were from Santa Cruz Inc. (USA). Anti-PI-3-K g-subunit (aa: 562 ± 724) and anti-cortactin (4F11) antibodies were generously given to us by UCL Ludwig Institute for Cancer Research, London and Dr JT Parsons (Virginia, USA), respectively. Radioactive compounds were from Amersham (UK). Peroxidase-labelled anti-mouse and anti-rabbit antibodies were from Jackson Immunodiagnostics (USA).
Preparation of total lysate, detergent-soluble and cytoskeletal fractions
Total cell lysate was prepared from sub-con¯uent (90%) serum-starved or HGF/SF-stimulated harvested in ice-cold PBS and lysed in lysis buer (LB: 10 mM Tris-HCl, pH 7.4, 1% Triton X-100, 0.5% Nonidet P-40, 150 mM NaCl, 0.2 mM sodium orthovanadate 1 mM Phenylmethyl sulphonyl¯uoride (PMSF), 40 mg/ml leupeptin and 45 mg/ml aprotinin).
Detergent-soluble and insoluble fractions were prepared as described (Provenzano et al., 1998) , by scraping the cells in HEPES buer containing 25 mM HEPES, pH 7.4, 2 mM MnCl 2 , 1 mM PMSF, 0.2 mM vanadate, 1% Triton X-100, 1 mM Phenylmethyl sulphonyl¯uoride (PMSF) and protease inhibitors as in LB. Cells were then incubated on ice for 10 min and mixed by inverting the tubes at approximately 30 min intervals during the incubation. The mixture was centrifuged for 5 min at 15 000 g and the supernatant was de®ned as the detergent-soluble. The pellets were resuspended in LB buer and represented the detergent-insoluble or cytoskeletal fraction.
Immunoprecipitation and Western blotting analysis
Cell lysates were supplemented with the appropriate antibody and incubated at 48C for 2 h and for further 30 min with Protein-A Sepharose (Boehringer-Mannheim). Complexes were washed three times with LB lacking protease inhibitors and protein species were eluted by heating in Laemmli sample buer. Eluted proteins were immunoblotted and probed with anti-MET, 4F11 (cortactin) or PTyr antibodies. Reactive species were visualized using an enhanced chemiluminescence (ECL) kit (Pierce). Blots for further probing, were stripped in 62.5 mM, Tris-HCl, pH 6.7, containing 2% Sodium Dodecyl Sulphate and 100 mM b-mercaptoethanol, for 30 min at 508C.
Purification of recombinant proteins and in vitro association
Cortactin cDNA was subcloned into the pGEX-2T vector and expressed as glutathione S-transferase (GST) fusion protein in Escherichia coli, as previously described (Weidner et al., 1993) . Fusion proteins, GST-Grb2, GST-P49LGrb2 (-SH3 mutant) and GST-R86K Grb2 (-SH2 mutant), were puri®ed also as described (Meissner et al., 1995) . 1 ± 1.5 mg of lysate protein was incubated with either GST, GST-cortactin, GST.294-526, GST.55-292, or GST-Grb2 fusion proteins, for 2 h at 48C. The beads were collected, washed three times with lysis buer (LB) and bound species were released by heating in 46Laemmli sample buer, followed by SDS ± PAGE and immunoblotting analysis.
In vitro kinase assays
MET or c-Src species from A431 cells treated with or without HGF/SF were immunoprecipitated and immune complexes were collected with protein A-Sepharose, washed three times with LB and once with kinase buer. The anti-c-src and anti-MET antibodies were calculated to be in excess over c-Src and MET cellular proteins. In vitro kinase reactions were carried out in kinase buer (20 ml, 20 mM PIPES, pH 7.0, 10 mM MnCl 2 , 0.1 mM sodium orthovanadate) in the presence of 10 mCi of [g-32 P]ATP (sp. activity 47.000 Ci/ mmol), for 10 min at 308C. Enolase, a c-Src kinase substrate, and/or PP2 were included in the reactions carried out to determine c-Src kinase activity. Phosphorylated species were released by heating in 46Laemmli sample buer followed by SDS ± PAGE. In some experiments, gels were incubated in 1 M KOH at 458C for 30 min to hydrolyze serine and threonine phosphorylation (Rahimi et al., 1998) .
Transfection of A431 cells with Grb2 dominant-negative mutants
Dominant-negative Grb2 SH2/SH3 expression constructs were generated by mutating the conserved arginine of the FLVRES sequence within the SH2 domain to lysine (Tanaka et al., 1995) . The tryptophan within the tryptophan doublet of the SH3 domain was also mutated to lysine. The capacity of mutants to eliminate ligand binding of the mutated domain without interfering with the binding capacity of the unmutated domain was assayed as previously described (Tanaka et al., 1995) . A431 cells were transfected with wild-type and dominant-negative Grb2 mutants, using the calcium phosphate methodology (Chen and Okayama, 1987) . After transfection, cells were serum-starved for 36 h and stimulated with 50 ng/ml of HGF/SF for 15 min prior to lysis in LB. Protein expression of the transfected dominantnegative Grb2 was examined by immunoblotting using antiGrb2 speci®c antibodies (Transduction Laboratories). Similar levels of expression of the Grb2 mutants were con®rmed (not shown). Lysates from transfected cells were then immunoprecipitated with 4F11 antibody and immunoblotted as described above. Myc-expressing clones were con®rmed by immunoblotting A431 lysates with 9E10 Myc antibody. Cell migration in A431 clones expressing either Myc-Cort F421F466F482 or the vector alone was estimated on the wounds of cultured cells stimulated with HGF/SF. Wounds were created by a rubber policeman and migration was determined at dierent time points as previously described (Huang et al., 1998) .
